PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2019 | 1 |
| 2020 | 68 |
| 2021 | 62 |
| 2022 | 70 |
| 2023 | 67 |
| 2024 | 76 |
| 2025 | 72 |
| 2026 | 55 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Nat Cancer"[Journal]
471
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Author Correction: A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance.
- Whitehead CE, Ziemke EK, Frankowski-McGregor CL, Mumby RA, Chung J, Li J, Osher N, Coker O, Baladandayuthapani V, Kopetz S, Sebolt-Leopold JS.
- Nat Cancer. 2026 Oct;7(10):1660. doi: 10.1038/s43018-026-01269-1.
- PMCID: PMC13694215
Whitehead CE, et al.Nat Cancer. 2026.PMCID: PMC13694215 -
An iron-regulated methionine redox axis governs adipose browning and cancer cachexia.
- Nam JS, Ahn SS, Shin Y, Vargas-Castillo A, Dixon MS, Ahmadi P, Schilling K, Zandkarimi F, Chen A, Yoon NA, Cullen H, Sun Y, Caffrey TC, Klute KA, Swanson BJ, Lu J, Pan S, Chen Y, Ichimiya S, Kim G, Genkinger JM, Sugahara K, Kluger MD, Grandgenett P, Hollingsworth MA, Berchowitz L, Ferrante AW Jr, Zeltser LM, Diano S, Chio IIC.
- Nat Cancer. 2026 Sep 22;7(10):1514-1532. doi: 10.1038/s43018-026-01234-y.
- PMCID: PMC13694233
Nam JS, et al.Nat Cancer. 2026.PMCID: PMC13694233 -
Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression.
- Lai P, Liu L, Pernigoni N, Du Y, Braga D, Troiani M, Attanasio G, Li Y, Song P, Pasquini E, Rezzonico Jost T, Huang X, Maddalena M, Mosole S, Rinaldi A, Pecoraro G, Pedrani M, Valdata A, Bancaro N, Maraccani L, De Giani A, Yuan W, Gallagher L, Chandran K, Flohr P, Rescigno P, Reitano G, Morlacco A, Dal Moro F, Giacomini I, Montopoli M, Brunelli M, Pedron S, Pereira Mestre R, Gharaibeh RZ, Jobin C, Gillessen Sommer S, de Bono J, Alimonti A.
- Nat Cancer. 2026 Sep 9;7(10):1592-1609. doi: 10.1038/s43018-026-01229-9.
- PMCID: PMC13694241
Lai P, et al.Nat Cancer. 2026.PMCID: PMC13694241 -
Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance.
- Tang H, Xie P, Ahn J, Choi MR, Fan J, Chen S, Zhang Y, Zhang B.
- Nat Cancer. Author manuscript. 2026 May 19;7(8):1261-1279. doi: 10.1038/s43018-026-01174-7.
- PMCID: PMC13633844
Tang H, et al.Nat Cancer. Author manuscript. 2026.PMCID: PMC13633844 -
Copper depletion boosts CNS leukemia therapy by inhibiting nucleotide synthesis through impairment of mitochondrial complex IV activity.
- Wong AYL, Myers JW, Prakash G, Ma A, Brook JR, Petrova B, Bulut B, White R 3rd, Merz C, de Souza M, Maynard AG, Wang P, Yu A, Pohl NK, Weitman M, Silverman LB, Stegmaier K, Churchman LS, Cole PD, Brady DC, Kanarek N.
- Nat Cancer. Author manuscript. 2026 May 25;7(8):1227-1242. doi: 10.1038/s43018-026-01177-4.
- PMCID: PMC13618977
Wong AYL, et al.Nat Cancer. Author manuscript. 2026.PMCID: PMC13618977 -
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.
- Garfinkle EAR, Perales-Linares R, Gimple RC, Livingstone AJ, Roberts KF, Butt OH, Goedegebuure SP, McLellan MD, Chang GS, Hundal J, Yan J, Navarro JB, Paxton SA, Chattopadhyay S, Cooch N, Perales-Puchalt A, Stavroulaki K, Rochestie S, Peters J, Junker B, Campian JL, Chheda MG, Chicoine MR, Kim AH, Willie JT, Zipfel GJ, Dowling JL, Miller CA, Griffith OL, Griffith M, Gillanders WE, Miller KE, Mardis ER, Sardesai NY, Dunn GP, Johanns TM.
- Nat Cancer. 2026 Sep;7(9):1469. doi: 10.1038/s43018-026-01243-x.
- PMCID: PMC13600915
Garfinkle EAR, et al.Nat Cancer. 2026.PMCID: PMC13600915 -
L-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial.
- Gong J, Muranaka H, Choi SY, Tighiouart M, Bhute S, Aja ER, Jacobs JP, Stotland A, Van Eyk J, Elmadbouh OHM, Edderkaoui M, Tanaka S, Furuya H, Osipov A, Lorber J, Billet S, Morris A, Ten Hoeve-Scott J, Graeber T, Pandol SJ, Hendifar A, Bhowmick NA.
- Nat Cancer. 2026 Aug 31;7(9):1406-1418. doi: 10.1038/s43018-026-01225-z.
- PMCID: PMC13600916
Gong J, et al.Nat Cancer. 2026.PMCID: PMC13600916 -
Galanin impairs tumor immunity in glioblastoma by promoting infiltration and ferroptosis resistance of myeloid-derived suppressor cells.
- Pang L, Liu Y, Zhou F, Guo S, Khan F, Ali H, Shah H, Huber S, Kofler B, Horbinski CM, Chen P.
- Nat Cancer. 2026 Aug 25;7(9):1387-1405. doi: 10.1038/s43018-026-01221-3.
- PMCID: PMC13600933
Pang L, et al.Nat Cancer. 2026.PMCID: PMC13600933 -
Fc-optimized GITR antibody enhances a CD4 T cell-dendritic cell crosstalk to promote antitumor immunity.
- Avraham Y, Barth N, Yair Bar-On T, Toval B, Habshush Menachem A, Blanga J, Herzog E, Rotem H, Shapir Itai Y, Feferman T, Biton M, Dahan R.
- Nat Cancer. 2026 Aug 5;7(9):1419-1435. doi: 10.1038/s43018-026-01207-1.
- PMCID: PMC13600942
Avraham Y, et al.Nat Cancer. 2026.PMCID: PMC13600942 -
Coupling dead cell recognition to Fcγ receptors augments anticancer immunity.
- Castro-Dopico T, Piot C, Buck MD, Gandullo-Sánchez L, Lim KHJ, Gonzales GA, Rosendahl N, Schulz O, Stainier W, Vash B, Maiocco S, Henry CM, Frederico B, Lee S, Zhang AB, Rogers NC, Bordoloi J, Roustan C, Kjaer S, Trikha M, Stauss H, Hazini A, Radford KJ, Tuong ZK, Canton J, Mehta R, Reis E Sousa C.
- Nat Cancer. 2026 May 20;7(9):1350-1367. doi: 10.1038/s43018-026-01168-5.
- PMCID: PMC13600936
Castro-Dopico T, et al.Nat Cancer. 2026.PMCID: PMC13600936